Abel Torres-Espin is assistant professor at the School of Public Health Sciences at the University of Waterloo in Canada; adjunct professor at the University of Alberta and assistant adjunct professor at the Brain and Spinal Injury Center in the Weill Institute of Neurosciences at University of California, San Francisco.
Abel Torres-Espin
Assistant adjunct professor
Brain and Spinal Injury Center (BASIC) University of California, San Francisco
From this contributor
By
Adam Ferguson, Hannah Radabaugh, Abel Torres-Espin
4 March 2024
7 min read
Pooling data points to new potential treatment for spinal cord injury
By gathering raw data from multiple labs, we identified an overlooked predictor of recovery after spinal cord injury. Many more insights remain trapped in scattered data.
Explore more from The Transmitter
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
By
Sheena Josselyn
9 June 2025 | 8 min read
How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.
How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.
By
Calli McMurray
6 June 2025 | 6 min read
NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.
NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.
By
Angie Voyles Askham
5 June 2025 | 5 min read